Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Journal of clinical microbiology - 1 Feb 2001

Hannan M M, Desmond E P, Morlock G P, Mazurek G H, Crawford J T

Abstract excerpt

Mycobacterium bovis is naturally resistant to the antituberculosis drug pyrazinamide (PZA). To determine whether all Mycobacterium tuberculosis complex isolates demonstrating PZA monoresistance were truly M. bovis, we examined the phenotype and genotype of isolates reported as PZA monoresistant in five counties in California from January 1996 through June 1999. Isolates reported by local laboratories to be PZA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases
Share to Antitubercular Agents
Share to California

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Mycobacterium bovis

Share to Mycobacterium tuberculosis

Share to Pyrazinamide

Share to Tuberculosis

Source

Open in PubMed Open full text

Identifiers

PMID: 11158123
DOI: 10.1128/JCM.39.2.647-650.2001
PMCID: PMC87792

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.PMID 11158123Read ↗

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.Semantic proximity Read ↗

Non-pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?Semantic proximity Read ↗

Molecular characterization of Mycobacterium bovis isolates from patients with tuberculosis in Baja California, Mexico.Semantic proximity Read ↗

Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.Semantic proximity Read ↗

Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.Semantic proximity Read ↗

Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Semantic proximity Read ↗

Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.Semantic proximity Read ↗

Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.Semantic proximity Read ↗

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.Semantic proximity Read ↗

Widespread pyrazinamide-resistant Mycobacterium tuberculosis family in a low-incidence setting.Semantic proximity Read ↗

pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.